This page may have documents that can’t be read by screen reader software. For help with these documents, management can call 1-855-439-3641 and bargained can call 1-800-621-7336.

Gender Dysphoria Services and Treatment

Gender dysphoria services, including gender reassignment surgery (GRS), may be covered when medically necessary and if the individual meets all criteria.

A predetermination of benefits must be submitted to evaluate medical necessity or medical appropriateness of the proposed treatment. If there is a discrepancy between the Medical Policy and a member's benefit plan, summary plan description or contract, the benefit plan, summary plan description or contract will govern.

Blue Cross and Blue Shield of Illinois stands by our core values of integrity, respect, commitment, caring and excellence. We support our lesbian, gay, bisexual, transgender, questioning/queer (LGBTQ+) members to better understand the health care needs of our communities. Search for primary care providers, specialists, therapists, dentists and other health care professionals that welcome LGBTQ+ individuals and families. 

You Must Meet the Following Criteria Considered for GRS

The individual being considered for GRS surgery must meet all the following criteria. The individual must have:

  • Reached the age of at least 18 years; and
  • The capacity to make a fully informed decision and to consent for treatment; and
  • Been diagnosed with persistent, well-documented gender dysphoria; and
  • Lived continuously for at least 12 months in the gender role (real life experiences) that is consistent with the preferred gender, without periods of time returning the individual's original gender; and
  • Completed at least 12 months of continuous hormonal sex reassignment therapy of either male-to-female (MtF) or female-to-male (FtM); and
  • Undergone a urological examination to identify and treat abnormalities of the genitourinary tract; and
  • Been an active participant in a recognized gender identity treatment program; and
  • Referrals for surgery from the individual's qualified mental health professionals competent in the assessment and treatment of gender dysphoria, which include:
    • One referral required for breast/chest surgery that is mastectomy, chest reconstruction, or breast augmentation; and
    • One independent referral required for genital surgery that is hysterectomy, salpingo-oophorectomy, orchiectomy, and/or other genital reconstructive procedures.

Note regarding mental health services: If the first referral is from the individual's psychotherapist, the second referral should be from a clinician who has only had an evaluative role with the individual. Two separate letters, or one letter signed by both (if both are practicing within the same clinic or program), may be sent. Psychotherapy is not required for GRS except when the mental health professional's initial assessment recommends psychotherapy that specifies the goals of treatment and estimates its frequency and duration throughout the real life experience.

Primary Sexual Characteristic Gender Reassignment Chest and/or Genital Surgeries:

Male-to-Female (MtF) surgical procedures performed as part of gender reassignment services for an individual who has met the above criteria for gender dysphoria may be considered medically necessary and include the following:

  • Breast modification, including but not limited to breast enlargement, breast augmentation, mastopexy, implant insertion, and silicone injections, and nipple or areola reconstruction;
  • Clitoroplasty;
  • Coloproctostomy;
  • Colovaginoplasty;
  • Labioplasty;
  • Orchiectomy;
  • Penectomy;
  • Penile skin inversion;
  • Repair of introitus;
  • Vaginoplasty with construction of vagina with graft; and/or
  • Vulvoplasty.

Female-to-Male (FtM) surgical procedures performed as part of gender reassignment services for an individual who has met the above criteria for gender dysphoria may be considered medically necessary and include the following:

  • Hysterectomy;
  • Metoidioplasty;
  • Phalloplasty;
  • Placement of an implantable erectile prostheses;
  • Placement of testicular prostheses;
  • Salpingo-oophorectomy;
  • Scrotoplasty;
  • Subcutaneous mastectomy, including nipple or areola reconstruction;
  • Vaginectomy (colpectomy);
  • Urethroplasty; and/or
  • Urethromeatoplasty.

Secondary Sexual Characteristic (Masculinizing or Feminizing) Gender Reassignment Surgeries and Related Services:

Procedures or services to create and maintain gender specific characteristics (masculinization or feminization) as part of the overall desired gender reassignment services treatment plan may be considered medically necessary for the treatment of gender dysphoria ONLY. These procedures may include the following:

  • Abdominoplasty;
  • Blepharoplasty;
  • Brow lift;
  • Calf implants;
  • Cheek implants;
  • Chin or nose implants;
  • External penile prosthesis (vacuum erection devices);
  • Face lift (rhytidectomy);
  • Facial bone reconstruction/sculpturing/reduction, includes jaw shortening;
  • Forehead lift or contouring;
  • Hair removal (may include donor skin sites) or hair transplantation (electrolysis or hairplasty);
  • Laryngoplasty;
  • Lip reduction or lip enhancement;
  • Liposuction/lipofilling or body contouring or modeling of waist, buttocks, hips, and thighs reduction;
  • Neck tightening;
  • Pectoral implants;
  • Reduction thyroid chondroplasty or trachea shaving (reduction of Adam’s apple);
  • Redundant/excessive skin removal;
  • Rhinoplasty (nose correction);
  • Skin resurfacing;
  • Testicular expanders;
  • Voice modification surgery; and/or
  • Voice (speech) therapy or voice lessons.

Gender specific preventive medicine services may be covered for GRS individuals who are planning to undergo or have undergone GRS:

  • Breast cancer screening for FtM individuals who have not yet had a mastectomy;
  • Cervical cancer screening for FtM individuals who have not yet had a hysterectomy with or without salpingo-oophorectomy; or
  • Prostate cancer screening for MtF individuals who have opted to retain their prostate.